Published in Proc Natl Acad Sci U S A on May 26, 1998
The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71
Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol (2002) 2.93
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Comprehensive analysis of ebola virus GP1 in viral entry. J Virol (2005) 2.56
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol (2007) 2.16
Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J Virol (2000) 2.15
Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J Virol (2005) 2.05
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47
Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. J Virol (2008) 1.40
Membrane fusion mediated by coiled coils: a hypothesis. Biophys J (2000) 1.38
A discrete stage of baculovirus GP64-mediated membrane fusion. Mol Biol Cell (1999) 1.25
Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J (2001) 1.23
Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol (1999) 1.21
Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell (2015) 1.18
Structural basis for differential neutralization of ebolaviruses. Viruses (2012) 1.15
The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol (2003) 1.13
Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc Natl Acad Sci U S A (2004) 1.12
The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J Virol (2006) 1.09
Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virol J (2009) 1.04
Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects. Protein Sci (2011) 1.02
An update on the use of antibodies against the filoviruses. Immunotherapy (2013) 1.01
Intracellular events and cell fate in filovirus infection. Viruses (2011) 1.01
Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol (2006) 0.98
Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle. Biochemistry (2012) 0.97
Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry. Virology (2015) 0.94
Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies. J Virol (2009) 0.91
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. MBio (2016) 0.87
Mutations in the cytoplasmic domain of the Newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicity. J Virol (2013) 0.83
Beyond anchoring: the expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J Virol (2012) 0.83
Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol (2009) 0.82
Characterizing alpha helical properties of Ebola viral proteins as potential targets for inhibition of alpha-helix mediated protein-protein interactions. F1000Res (2014) 0.81
Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. J Mol Biol (2016) 0.79
The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection. J Virol (2011) 0.79
Simple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoprotein. J Biol Chem (2011) 0.78
The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry(). Virol Sin (2009) 0.77
Flexibility of the Head-Stalk Linker Domain of Paramyxovirus HN Glycoprotein Is Essential for Triggering Virus Fusion. J Virol (2016) 0.75
The MuLV 4070A G541R Env mutation decreases the stability and alters the conformation of the TM ectodomain. Virology (2007) 0.75
Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging. Sci Rep (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
SNAREpins: minimal machinery for membrane fusion. Cell (1998) 16.97
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Core structure of gp41 from the HIV envelope glycoprotein. Cell (1997) 16.18
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell (1993) 10.66
A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science (1993) 10.16
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med (1991) 9.28
A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell (1993) 8.26
Evidence that the leucine zipper is a coiled coil. Science (1989) 8.00
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses (1989) 7.34
A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol (1995) 7.30
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell (1997) 5.72
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet (1977) 5.32
Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J (1994) 5.02
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol (1990) 3.59
Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A (1997) 3.57
Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science (1985) 3.27
Oligomeric structure of a prototype retrovirus glycoprotein. Proc Natl Acad Sci U S A (1988) 3.06
Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell (1996) 2.70
High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene (1989) 2.63
Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J Biol Chem (1998) 2.57
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry (1995) 2.57
A conserved domain is present in different families of vesicular fusion proteins: a new superfamily. Proc Natl Acad Sci U S A (1997) 2.42
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett (1992) 2.24
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J (1996) 2.21
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol (1988) 2.21
Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology (1986) 2.13
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Distinct domains of syntaxin are required for synaptic vesicle fusion complex formation and dissociation. Neuron (1995) 1.94
Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. Virology (1977) 1.93
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol (1995) 1.60
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest (1993) 1.57
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.35
Combining accurate defocus with low-dose imaging in high resolution electron microscopy of biological material. J Microsc (1983) 1.18
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (1993) 8.75
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (1994) 7.13
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
Crystalline antigen from the influenza virus envelope. Nat New Biol (1972) 5.77
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A (1992) 5.02
Identification of self peptides bound to purified HLA-B27. Nature (1991) 4.88
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. Nucleic Acids Res (1978) 4.83
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol (1991) 4.44
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature (1989) 4.34
Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26
Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity. Eur J Immunol (1977) 4.05
Transcription of the influenza virus genome. Virology (1977) 4.02
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (1991) 3.84
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (1992) 3.82
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology (1969) 3.79
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol (1999) 3.72
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature (1977) 3.67
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60
The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 3.44
Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol (1983) 3.43
The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell (1992) 3.27
Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol (1999) 3.26
Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature (1992) 3.12
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (1995) 2.90
Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1975) 2.88
Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity (1999) 2.86
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med (1984) 2.81
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell (1992) 2.79
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology (1989) 2.74
Polypeptide synthesis in influenza virus-infected cells. Virology (1972) 2.70
H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology (2004) 2.67
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Refinement of the influenza virus hemagglutinin by simulated annealing. J Mol Biol (1990) 2.61
An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology (2002) 2.56
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature (1995) 2.55
Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol (2001) 2.52
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology (1997) 2.51
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol (1978) 2.50
Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature (1981) 2.49
Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell (1992) 2.47
A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol (1999) 2.47
Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli. J Mol Biol (1982) 2.46
The polypeptides of adenovirus-infected cells. J Gen Virol (1972) 2.43
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J (1990) 2.42
Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature (1998) 2.41
Crystallographic determination of symmetry of aspartate transcarbamylase. Nature (1968) 2.37